167 related articles for article (PubMed ID: 16953232)
1. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
[TBL] [Abstract][Full Text] [Related]
3. N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18(Ink4c) by the transforming mutant RET(C634R).
Kulkarni MV; Franklin DS
Mol Oncol; 2011 Feb; 5(1):24-35. PubMed ID: 21112821
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
Damo LA; Snyder PW; Franklin DS
Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
[TBL] [Abstract][Full Text] [Related]
5. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
6. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
[TBL] [Abstract][Full Text] [Related]
7. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
[TBL] [Abstract][Full Text] [Related]
8. Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice.
Hasegawa T; Enomoto A; Kato T; Kawai K; Miyamoto R; Jijiwa M; Ichihara M; Ishida M; Asai N; Murakumo Y; Ohara K; Niwa Y; Goto H; Takahashi M
Oncogene; 2008 Sep; 27(43):5684-95. PubMed ID: 18542059
[TBL] [Abstract][Full Text] [Related]
9. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
[TBL] [Abstract][Full Text] [Related]
10. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
11. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
Pei XH; Bai F; Smith MD; Xiong Y
Cancer Res; 2007 Apr; 67(7):3162-70. PubMed ID: 17409423
[TBL] [Abstract][Full Text] [Related]
12. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
13. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
14. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
16. The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.
Stein J; Milewski WM; Dey A
Islets; 2013; 5(4):156-69. PubMed ID: 23896637
[TBL] [Abstract][Full Text] [Related]
17. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
18. RNA interference reveals a requirement for both p18INK4c and p27Kip1 in B lymphopoiesis.
Wang YY; Li Z; Jiao D; Zhang Z; Shao X; Yuan J; Yu P
J Mol Cell Biol; 2010 Aug; 2(4):209-16. PubMed ID: 20671115
[TBL] [Abstract][Full Text] [Related]
19. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
20. p18INK4c and p27KIP1 are required for cell cycle arrest of differentiated myotubes.
Myers TK; Andreuzza SE; Franklin DS
Exp Cell Res; 2004 Nov; 300(2):365-78. PubMed ID: 15475001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
